Photodynamic Effect of Hypericin after Topical Application in the Ex Ovo Quail Chorioallantoic Membrane Model

Abstract Photosensitizing properties of hypericin are well known, and the chicken chorioallantoic membrane has previously been used to test photodynamic effects of hypericin and other substances. In our study the photodynamic effect of hypericin in the ex ovo quail chorioallantoic membrane model was evaluated. Steady-state and time-resolved fluorescence spectroscopy of hypericin solution in PEG-400 and its mixture in PBS was performed to assess and characterize the process of aggregation and disaggregation of hypericin during the drug formulation preparation. A therapeutical formulation (2 µg/g of embryo weight) was topically applied on CAM into the silicone ring. Hypericin was excited by diode laser with wavelength 405 nm, fluence rate 140 mW/cm2, and fluence 16.8 J/cm2. Hypericin in 100 % PEG-400 exhibits typical fluorescence spectra with a maximum of about 600 nm, while hypericin 10% PEG-400 formulation exhibits almost no fluorescence. Time resolved spectra analysis showed fluorescence decay of hypericin in 100 % PEG-400 solution with a mean lifetime of 5.1 ns and in 10 % PEG 4.1 ns. Damage of quail chorioallantoic membrane vasculature after photodynamic therapy ranged from hemorrhage and vanishing of capillary vessels to thrombosis, lysis, and hemorrhage of larger vessels. The presented findings suggest that quail embryos can be used as a suitable model to test the effect of hypericin and other photodynamic compounds.

[1]  Pavol Miskovsky,et al.  Towards increased selectivity of drug delivery to cancer cells: development of a LDL-based nanodelivery system for hydrophobic photosensitizers , 2012, Optics & Photonics - NanoScience + Engineering.

[2]  A. Griffioen,et al.  Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea. , 2012, Biochimica et biophysica acta.

[3]  M. Tsuboi,et al.  Gastric mucosal changes induced by polyethylene glycol 400 administered by gavage in rats. , 2011, The Journal of toxicological sciences.

[4]  M. Olivo,et al.  New Frontier in Hypericin-Mediated Diagnosis of Cancer with Current Optical Technologies , 2011, Annals of Biomedical Engineering.

[5]  M. Medina,et al.  Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene , 2011, PloS one.

[6]  T. Efferth,et al.  Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol. , 2011, Planta medica.

[7]  A. Chlumská,et al.  Mucosal changes after a polyethylene glycol bowel preparation for colonoscopy are less than those after sodium phosphate. , 2011, Ceskoslovenska patologie.

[8]  T. Efferth,et al.  Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. , 2011, Journal of ethnopharmacology.

[9]  A. Kozubík,et al.  Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin. , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[10]  R. Gurny,et al.  MPEG‐hexPLA Micelles as Novel Carriers for Hypericin, a Fluorescent Marker for Use in Cancer Diagnostics , 2011, Photochemistry and photobiology.

[11]  J. Uličný,et al.  On the diffusion of hypericin in dimethylsulfoxide/water mixtures-the effect of aggregation. , 2011, The journal of physical chemistry. B.

[12]  Huajiang Wei,et al.  Synergistic Effect of Ultrasound and Thiazone–PEG 400 on Human Skin Optical Clearing In Vivo , 2010, Photochemistry and photobiology.

[13]  E. Gálová,et al.  Genotoxicity and antigenotoxicity evaluation of non‐photoactivated hypericin , 2010, Phytotherapy research : PTR.

[14]  M. Zeman,et al.  Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane , 2010 .

[15]  K. Soo,et al.  Clinical application of fluorescence endoscopic imaging using hypericin for the diagnosis of human oral cavity lesions , 2009, British Journal of Cancer.

[16]  R. Dědic,et al.  Time‐resolved Luminescence and Singlet Oxygen Formation After Illumination of the Hypericin–Low‐density Lipoprotein Complex , 2009, Photochemistry and photobiology.

[17]  R. Gurny,et al.  Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model. , 2009, Nanomedicine.

[18]  M. Olivo,et al.  Study of interaction of hypericin and its pharmaceutical preparation by fluorescence techniques. , 2009, Journal of biomedical optics.

[19]  R. Lansford,et al.  Japanese quail (Coturnix japonica) as a laboratory animal model , 2008, Lab Animal.

[20]  J. Mikes,et al.  High Level of Low‐density Lipoprotein Receptors Enhance Hypericin Uptake by U‐87 MG Cells in the Presence of LDL , 2007, Photochemistry and photobiology.

[21]  Robert Gurny,et al.  The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. , 2007, Advanced drug delivery reviews.

[22]  K. Soo,et al.  Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model. , 2007, Journal of photochemistry and photobiology. B, Biology.

[23]  A. Chorvatova,et al.  Spectrally resolved time-correlated single photon counting: a novel approach for characterization of endogenous fluorescence in isolated cardiac myocytes , 2006, European Biophysics Journal.

[24]  Malini Olivo,et al.  Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. , 2006, Cancer letters.

[25]  G. Bormans,et al.  The impact of aggregation on the biodistribution of hypericin. , 2006, International journal of oncology.

[26]  Claudia Fruijtier-Pölloth.  Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. , 2005, Toxicology.

[27]  S. Rybárová,et al.  Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[28]  M. Medina,et al.  Hypericin in the dark inhibits key steps of angiogenesis in vitro. , 2005, European journal of pharmacology.

[29]  P. D. de Witte,et al.  Stability of different formulations and ion pairs of hypericin. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  R. Steiner,et al.  PDT with TOOKAD(®) studied in the chorioallantoic membrane of fertilized eggs. , 2005, Photodiagnosis and photodynamic therapy.

[31]  T. Theodossiou,et al.  Evidence for Intracellular Aggregation of Hypericin and the Impact on its Photocytotoxicity in PAM 212 Murine Keratinocytes¶ , 2004, Photochemistry and photobiology.

[32]  Michael R Hamblin,et al.  Photodynamic therapy: a new antimicrobial approach to infectious disease? , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[33]  A. Quesada,et al.  A Modified Chorioallantoic Membrane Assay Allows for Specific Detection of Endothelial Apoptosis Induced by Antiangiogenic Substances , 2004, Angiogenesis.

[34]  Gurmit Singh,et al.  Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. , 2003, Current drug targets. Cardiovascular & haematological disorders.

[35]  T. Roskams,et al.  Antivascular Tumor Eradication by Hypericin-mediated Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.

[36]  P. Agostinis,et al.  Hypericin in cancer treatment: more light on the way. , 2002, The international journal of biochemistry & cell biology.

[37]  P. Miškovský,et al.  Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules. , 2002, Current Drug Targets.

[38]  P. Parsons-Wingerter,et al.  Generational analysis reveals that TGF-beta1 inhibits the rate of angiogenesis in vivo by selective decrease in the number of new vessels. , 2000, Microvascular research.

[39]  M W Berns,et al.  Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers. , 1999, Journal of photochemistry and photobiology. B, Biology.

[40]  P. Parsons-Wingerter,et al.  A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. , 1998, Microvascular research.

[41]  P. Vanparys,et al.  Evaluation of the HET-CAM-TSA method as an alternative to the draize eye irritation test. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[42]  K König,et al.  Time-resolved in-vivo fluorescence of photosensitizing porphyrins. , 1993, Journal of photochemistry and photobiology. B, Biology.

[43]  E. Graevskiĭ.  [Photodynamic effect]. , 1951, Uspekhi sovremennoi biologii.